Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 684-597-9 | CAS number: 1072005-10-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- Expert Statement
- Type of information:
- other: Expert Statement
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Expert Statement, no study available
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
- Principles of method if other than guideline:
- Expert statement
- GLP compliance:
- no
- Details on test animals or test system and environmental conditions:
- not applicable
- Duration and frequency of treatment / exposure:
- not applicable
- Positive control reference chemical:
- not applicable
- Details on study design:
- not applicable
- Details on dosing and sampling:
- not applicable
- Statistics:
- not applicable
- Details on absorption:
- According to ECHA Guidance R.7c, the smaller the molecule the more easily it may be taken up via oral route (ECHA, 2014). Oral absorption is favoured for the test item as the molecular weight is below 500 g/mol. On the other hand, the low water solubility does not favour high absorption rates. Additionally, the test item is highly lipophilic (log Pow >4), therefore the uptake may be by micellular solubilisation. Taken together, the physiochemical properties indicate that the test item becomes sparsely bioavailable following the oral route. This assumption is supported by the results of the acute oral toxicity study in mice with the read across substance CAS 68583-51-7, where the highest concentration of 4600 mg/kg bw showed no effect.
The low water solubility of the substance does not favour high absorption rates. On the other hand, due to the good lipophilicity (log Pow values of 5.2 – 8.7) the uptake into the stratum corneum will be high, even if the rate of penetration may be limited by the rate of transfer between the stratum corneum and the epidermis. Besides that, dermal uptake is favoured for substances with a molecular weight < 100 g/mol. Therefore the molecular weight of the test item would not indicate absorption through skin. This is also supported by the results of the acute dermal toxicity study indicating no systemic signs up to 2000 mg/kg bw with the read across substance CAS 853947-59-8.
Due to the low volatility (vapour pressure <0.15 Pa and boiling point above 200°C) it is unlikely that the substance will be available as a vapour to a large extend, but if it is the case absorption via inhalation route is unlikely due to low water solubility and high log Pow value, disabling uptake directly across the respiratory tract epithelium by passive diffusion. The acute inhalation studies conducted with the read across substance CAS 68583-51-7 suggested a low potential for toxicity via inhalation (LC50 > 200ppm, equivalent to 5952 mg/m³). - Details on distribution in tissues:
- In general, the smaller the molecule the wider the distribution. Based on the molecular weight (over 300 g/mol) and the liphophilicity (log Pow >4) it is assumed, that if absorbed, the test item is distributed into cells and not present in the blood.
- Details on excretion:
- According to the physicochemical properties of the substance, molecular weight, lipophilic characteristics and water solubility, urine excretion, breast milk, sweat and exfoliation are the main routes of elimination.
- Details on metabolites:
- During metabolism more polar substances are assumed to be formed to facilitate a more rapid excretion via urine. The main metabolism products are C8-10 and alcohols like 1,3 propanediol.
- Conclusions:
- Bioaccumulation of the test substanceis not considered critical based on expert statement.
- Executive summary:
Based on physicochemical characteristics, particularly water solubility and octanol-water partition coefficient, absorption by the oral and dermal route is expected. This assumption is further supported by the results of the oral and dermal acute toxicity studies, revealing no effects at very high doses. Absorption via inhalation route is unlikely, but can not be excluded. Bioaccumulation of the test item or its breakdown products will not occur.
Reference
Description of key information
Based on physicochemical characteristics, particularly water solubility and octanol-water partition coefficient, absorption by the oral and dermal route is expected. This assumption is further supported by the results of the oral and dermal acute toxicity studies, revealing no effects at very high doses. Absorption via inhalation route is unlikely, but can not be excluded. Bioaccumulation of the test item or its breakdown products will not occur.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The test item is a lowly viscous liquid at room temperature with a molecular weight of 328 -384 g/mol.The substance is not good soluble in water (<0.15 mg/L at 25 °C). The log Pow was determined to be 7.77. The test item has a vapour pressure of 0.00577 Pa at 20 °C.
Absorption
According to ECHA Guidance R.7c, the smaller the molecule the more easily it may be taken up via oral route (ECHA, 2014). Oral absorption is favoured for the test item as the molecular weight is below 500 g/mol. On the other hand, the low water solubility does not favour high absorption rates. Additionally, the test item is highly lipophilic (log Pow >4), therefore the uptake may be by micellular solubilisation.Taken together, the physiochemical properties indicate that the test item becomes sparsely bioavailable following the oral route.This assumption is supported by the results of the acute oral toxicity study in mice with the read across substance CAS 68583-51-7, where the highest concentration of 4600 mg/kg bw showed no effect.
The low water solubility of the substance does not favour high absorption rates. On the other hand, due to the good lipophilicity (log Pow values of 5.2 – 8.7) the uptake into the stratum corneum will be high, even if the rate of penetration may be limited by the rate of transfer between the stratum corneum and the epidermis. Besides that, dermal uptake is favoured for substances with a molecular weight < 100 g/mol. Therefore the molecular weight of the test item would not indicate absorption through skin.This is also supported by the results of the acute dermal toxicity study indicating no systemic signs up to 2000 mg/kg bw with the read across substance CAS 853947-59-8.
Due to the low volatility (vapour pressure <0.15 Pa and boiling point above 200°C) it is unlikely that the substance will be available as a vapour to a large extend, but if it is the case absorption via inhalation route is unlikely due to low water solubility and high log Pow value, disabling uptake directly across the respiratory tract epithelium by passive diffusion. The acute inhalation studies conducted with the read across substance CAS 68583-51-7 suggested a low potential for toxicity via inhalation (LC50 > 200ppm, equivalent to 5952 mg/m³).
Distribution
In general, the smaller the molecule the wider the distribution. Based on their molecular weight (over 300 g/mol) and the liphophilicity (log Pow >4) it is assumed, that if absorbed, the substance is distributed into cells and is not present in the blood.
Metabolism
The genotoxicity studies indicated no remarkable differences in regard to genotoxicity and cytotoxicity in the presence or absence of metabolic activation systems. Thus a metabolic activation to more toxic metabolites is not to be expected.
During metabolism more polar substances are assumed to be formed to facilitate a more rapid excretion via urine. The main metabolism products are C8-10 and alcohols like 1,3 propanediol.
Excretion
According to the physicochemical properties of the substance, molecular weight, lipophilic characteristics and water solubility, urine excretion, breast milk, sweat and exfoliation are the main routes of elimination.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.